The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Defense Mechanisms against Influenza Virus Infection in the Respiratory Tract Mucosa
Open accessAbstract
The respiratory tract mucosa is not only the site of infection for influenza viruses but also the site of defense against virus infection. Viruses are initially detected and destroyed non-specifically by innate immune mechanisms, but if the viruses escape the early defense mechanisms, they are detected and eliminated specifically by adaptive immune mechanisms. The major adaptive immune mechanisms are as follows. (i) Specific secretory-IgA (S-IgA) antibodies (Abs) and CTLs (CD8+ cytotoxic T lymphocytes) are involved in the recovery from influenza following viral infection of naive mice. (ii) Preexisting specific S-IgA and IgG Abs in the immunized animals are involved in viral elimination by forming virus-Ig complexes shortly after re-infection. By their polymeric nature, the S-IgA Abs, which are carried to the mucus by transepithelial transport used for dimeric IgA (dIgA) Abs, provide not only protection against homologous virus infection but also cross-protection against drift virus infection. The IgG Abs, which transude from the serum to the mucus by diffusion, provide protection against homologous virus infection. They are largely distributed on the alveolar epithelia to prevent influenza pneumonia. (iii) In the absence of Abs in the pre-immunized animals, the production of specific IgA and IgG Abs by B memory cells is accelerated after re-infection, and these antibodies play a role in viral elimination from day 3 onwards after re-infection. (iv) In epithelial cells of infected animals, specific dIgA Abs being trafficked through the epithelial cells may be involved in the prevention of viral assembly by binding to newly synthesized viral proteins. (v) In the pre-immunized animals, CTL production by memory T cells is also accelerated and these cells appear to participate in the killing of the host cells infected with different subtype viruses (within the same type) from day 3 onwards after re-infection. (vi) Similarly, memory Th1 cells that mediate an accelerated delayed-type hypersensitivity response are involved in blockade of virus replication by secreting IFN-gamma in mice challenged with different subtype viruses. These defense mechanisms suggest that the development of a mucosal vaccine, capable of inducing S-IgA Abs, which provide cross-protection against variant viruses within the same subtype, serum IgG Abs to prevent lethal influenza pneumonia and CTLs, which provide broad cross-protection against different subtype viruses, is strategically important to control influenza.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 5×
“Therefore, new and effective adjuvants may arise from a screen of materials that stimulate the function of APCs, including ganglioside GM1 and ligands of several TLRs (18,22-29).”
BackgroundInfluentialRecognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Heterogeneity of Cytokine Secretion Patterns and Functions of Helper T Cells
Mosmann, T. R., & Coffman, R. L. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60652-5 · Cited by 1,106
Cher, D. J., & Mosmann, T. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3688 · Cited by 957
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., & Steffen, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030595 · Cited by 916
The mucosal immune system: from fundamental concepts to vaccine development
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., & Kiyono, H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90021-b · Cited by 903
Coffman, R. L., Lebman, D. A., & Shrader, B. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.1039 · Cited by 577
The role of nasopharyngeal lymphoid tissue
Frieke Kuper, C., Koornstra, P. J., Hameleers, D. M. H., Biewenga, J., Spit, B. J., Duijvestijn, A. M., van Breda Vriesman, P. J. C., & Sminia, T. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90158-4 · Cited by 538
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
YAP, K. L., ADA, G. L., & MCKENZIE, I. F. C. (1978) · Nature · doi:10.1038/273238a0 · Cited by 520
Toll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 492
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes
Topham, D. J., Tripp, R. A., & Doherty, P. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5197 · Cited by 486
Beagley, K. W., Eldridge, J. H., Lee, F., Kiyono, H., Everson, M. P., Koopman, W. J., Hirano, T., Kishimoto, T., & McGhee, J. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.2133 · Cited by 447
Isolation and characterization of the intracellular MHC class II compartment
Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H. L., & Pieters, J. (1994) · Nature · doi:10.1038/369120a0 · Cited by 424
Couch, R. B., & Kasel, J. A. (1983) · Annual Review of Microbiology · doi:10.1146/annurev.mi.37.100183.002525 · Cited by 424
Bender, B. S., Croghan, T., Zhang, L., & Small, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.4.1143 · Cited by 381
Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R., & Doherty, P. C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.875 · Cited by 366
Perry, M., & Whyte, A. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01307-3 · Cited by 345
Regional specialization in the mucosal immune system: what happens in the microcompartments?
Brandtzaeg, P., Baekkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F.-E., Nilsen, E. M., & Yamanaka, T. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01413-3 · Cited by 342
Passive transfer of local immunity to influenza virus infection by IgA antibody
Renegar, K. B., & Small, P. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1972 · Cited by 322
The Immune Response to Influenza Infection
Ada, G. L., & Jones, P. D. (1986) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-71272-2_1 · Cited by 316
Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M., & Beale, J. (1984) · European Journal of Immunology · doi:10.1002/eji.1830140414 · Cited by 314
Kopf, M., Abel, B., Gallimore, A., Carroll, M., & Bachmann, M. F. (2002) · Nature Medicine · doi:10.1038/nm0402-373 · Cited by 311
Mazanec, M. B., Coudret, C. L., & Fletcher, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1339-1343.1995 · Cited by 295
Adaptation and Growth Characteristics of Influenza Virus at 25° C
MAASSAB, H. F. (1967) · Nature · doi:10.1038/213612a0 · Cited by 274
Overview of the Mucosal Immune System
Brandtzaeg, P. (1989) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74529-4_2 · Cited by 271
New strategies for using mucosal vaccination to achieve more effective immunization
Walker, R. I. (1994) · Vaccine · doi:10.1016/0264-410x(94)90112-0 · Cited by 257
Role of the B‐cell response in recovery of mice from primary influenza virus infection
Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G., & Maiese, K. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01009.x · Cited by 237
Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
Renegar, K. B., & Small, P. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2146-2148.1991 · Cited by 225
Zuercher, A. W., Coffin, S. E., Thurnheer, M. C., Fundova, P., & Cebra, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1796 · Cited by 206
Palladino, G., Mozdzanowska, K., Washko, G., & Gerhard, W. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2075-2081.1995 · Cited by 200
The Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice
Price, G. E., Gaszewska-Mastarlarz, A., & Moskophidis, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3996-4003.2000 · Cited by 192
Role of Interleukin-12 in Primary Influenza Virus Infection
Monteiro, J. M., Harvey, C., & Trinchieri, G. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4825-4831.1998 · Cited by 181
The Systemic and Mucosal Immune Response of Humans to Influenza A Virus
Murphy, B. R., & Clements, M. L. (1989) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-74529-4_12 · Cited by 171
Scherle, P. A., Palladino, G., & Gerhard, W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.212 · Cited by 167
Influenza Virus NS1 Protein Induces Apoptosis in Cultured Cells
Schultz-Cherry, S., Dybdahl-Sissoko, N., Neumann, G., Kawaoka, Y., & Hinshaw, V. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7875-7881.2001 · Cited by 165
Outcome of Influenza Infection: Effect of Site of Initial Infection and Heterotypic Immunity
Yetter, R. A., Lehrer, S., Ramphal, R., & Small, P. A. (1980) · Infection and Immunity · doi:10.1128/iai.29.2.654-662.1980 · Cited by 161
Stein-Streilein, J., Bennett, M., Mann, D., & Kumar, V (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.6.2699 · Cited by 159
Fujimoto, I., Pan, J., Takizawa, T., & Nakanishi, Y. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3399-3403.2000 · Cited by 156
Johnson, B. J. B., Costelloe, E. O., Fitzpatrick, D. R., Haanen, J. B. A. G., Schumacher, T. N., Brown, L. E., & Kelso, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538056100 · Cited by 156
Tamura, S., Funato, H., Hirabayashi, Y., Suzuki, V., Nagamine, T., Aizawa, C., & Kurata, T. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210602 · Cited by 153
Self-citationWiley, J. A., Hogan, R. J., Woodland, D. L., & Harmsen, A. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3293 · Cited by 146
In vivo proliferation of naïve and memory influenza-specific CD8 + T cells
Flynn, K. J., Riberdy, J. M., Christensen, J. P., Altman, J. D., & Doherty, P. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8597 · Cited by 144
Riberdy, J. M., Christensen, J. P., Branum, K. C., & Doherty, P. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9762-9765.2000 · Cited by 139
Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells
Benton, K. A., Misplon, J. A., Lo, C.-Y., Brutkiewicz, R. R., Prasad, S. A., & Epstein, S. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7437 · Cited by 132
How BCG Led to the Discovery of Immunostimulatory DNA
Tokunaga, T., Yamamoto, T., & Yamamoto, S. (1999) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.52.1 · Cited by 130
Hirabayashi, Y., Kurata, H., Funato, H., Nagamine, T., Aizawa, C., Tamura, S., Shimada, K., & Kurata, T. (1990) · Vaccine · doi:10.1016/0264-410x(90)90053-o · Cited by 125
Self-citationTamura, S.-I., Miyata, K., Matsuo, K., Asanuma, H., Takahashi, H., Nakajima, K., Suzuki, Y., Aizawa, C., & Kurata, T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3892 · Cited by 117
Self-citationTamura, S., Suzuki, Y., Iwasaki, T., Aizawa, C., Thompson, A., Kurata, T., Asanuma, H., & Chen, Z. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-2-291 · Cited by 108
Self-citationMurphy, B. R. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50034-8 · Cited by 107
Natural Cell-Mediated Immunity During Viral Infections
Welsh, R. M. (1981) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-68069-4_6 · Cited by 99
Mackenzie, C. D., Taylor, P. M., & Askonas, B. A. (1989) · PubMed · Cited by 92
Topham, D. J., Tripp, R. A., Sarawar, S. R., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1288-1291.1996 · Cited by 92
Jones, P. D., & Ada, G. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.614-619.1986 · Cited by 87
Hicks, J. T., Ennis, F. A., Kim, E., & Verbonitz, M. W. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.4.1437 · Cited by 77
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase
Asanuma, H., Inaba, Y., Aizawa, C., Kurata, T., & Tamura, S. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00165-7 · Cited by 70
Self-citationCytotoxic T Lymphocytes Specific for Influenza Virus
McMichael, A. J. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78530-6_5 · Cited by 68
Kweon, M., Yamamoto, M., Watanabe, F., Tamura, S., van Ginkel, F. W., Miyauchi, A., Takagi, H., Takeda, Y., Hamabata, T., Fujihashi, K., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/344526 · Cited by 67
Self-citationMUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION
Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.39 · Cited by 63
Muszkat, M., Greenbaum, E., Ben‐Yehuda, A., Oster, M., Yeu’l, E., Heimann, S., Levy, R., Friedman, G., & Zakay‐Rones, Z. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00481-4 · Cited by 60
Ben‐Yehuda, A., Joseph, A., Barenholz, Y., Zeira, E., Even‐Chen, S., Louria‐Hayon, I., Babai, I., Zakay‐Rones, Z., Greenbaum, E., Galprin, I., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00251-2 · Cited by 57
Epithelial and Hepatobiliary Transport of Polymeric Immunoglobulins
Brandtzæg, P., Krajči, P., Lamm, M. E., & Kaetzel, C. S. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50015-4 · Cited by 57
Bot, A. I., Reichlin, A., Isobe, H., Bot, S., Schulman, J. L., Yokoyama, W. M., & Bona, C. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5668-5672.1996 · Cited by 54
Nguyen, H. H., van Ginkel, F. W., Vu, H., Novak, M. J., McGhee, J. R., & Mestecky, J. F. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5495-5501.2000 · Cited by 50
Wyde, P. R., Wilson, M. R., & Cate, T. R. (1982) · Infection and Immunity · doi:10.1128/iai.38.3.1249-1255.1982 · Cited by 43
Yoshikawa, T., Matsuo, K., Matsuo, K., Suzuki, Y., Nomoto, A., Tamura, S., Kurata, T., & Sata, T. (2004) · Journal of General Virology · doi:10.1099/vir.0.79892-0 · Cited by 36
Self-citationBender, B. S., Bell, W. E., Taylor, S. D., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1195 · Cited by 36
Passive Immunization: Systemic and Mucosal
Renegar, K. B., & Small, P. A. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50035-x · Cited by 35
Gangemi, J. D., Hightower, J. A., Jackson, R. A., Maher, M. H., Welsh, M. G., & Sigel, M. M. (1983) · Infection and Immunity · doi:10.1128/iai.39.2.726-735.1983 · Cited by 18
Cited by
The airway epithelium: soldier in the fight against respiratory viruses
Vareille, M., Kieninger, E., Edwards, M. R., & Regamey, N. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-10 · Cited by 655
“Airway mucin production is induced by many respiratory viruses, including rhinovirus and influenza virus (278, 336).”
BackgroundGoffic, R. L., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., & Si-Tahar, M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020053 · Cited by 514
Le Goffic, R., Pothlichet, J., Vitour, D., Fujita, T., Meurs, E., Chignard, M., & Si-Tahar, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3368 · Cited by 436
Effects of air pollutants on the transmission and severity of respiratory viral infections
Domingo, J. L., & Rovira, J. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109650 · Cited by 387
Kumar, P., Singh, A. B., Arora, T., Singh, S., & Singh, R. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162163 · Cited by 380
Metadata
- Authors
- Tamura, S.-I., & Kurata, T.
- Venue
- Japanese Journal of Infectious Diseases
- Publisher
- Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis
- Published
- 2004-12-28
- Volume
- 57
- Issue
- 6
- Pages
- 236-247
- ISSN
- 1344-6304 (ISSN-L)
- 1884-2836
- OpenAlex
- W1778565685
- Cited by
- 276
- References
- 76
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.